| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Doudou Ma, Zhemin Lu, Qian Guo, Sha Zhu, Jin Gu, Yan Ding, Lianjie Sh. [Successful treatment of rheumatoid arthritis complicated with myasthenia gravis with low-dose rituximab: A case report]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences. vol 56. issue 6. 2024-12-18. PMID:39690779. |
she later exhibited drooping of the right eyelid and double vision, leading to a diagnosis of ocular myasthenia gravis (omg). |
2024-12-18 |
2024-12-21 |
Not clear |
| Sui Hsien Wong, Rebhi Abuzaitoun, Wayne T Cornblath, Eric R Eggenberger, Sangeeta Khanna, Tatiana Deveney, Joshua R Ehrlich, Chris A Andrews, Carolina Barnett-Tapia, Lindsey B De Lot. Multicenter Validation of the Ocular Myasthenia Gravis Rating Scale Questionnaire. Neurology. vol 104. issue 1. 2024-12-10. PMID:39657098. |
ocular myasthenia gravis (omg) causes disabling ocular symptoms of ptosis and diplopia, but a validated disease-specific patient-reported outcome measure (prom) has not been reported. |
2024-12-10 |
2024-12-21 |
Not clear |
| Prasana Nair Gengadharan, Wei Ting Ong, Jie Ying Tan, Nortina Shahrizaila, Khean Jin Goh, Cheng Yin Ta. Ocular Myasthenia gravis: determining the predictive factors of secondary generalisation. Acta neurologica Belgica. 2024-12-02. PMID:39621280. |
myasthenia gravis (mg) can be classified according to clinical features into ocular mg (omg) and generalised mg (gmg). |
2024-12-02 |
2024-12-06 |
Not clear |
| Julie M Shabto, Shanlee Stevens, Michael Kazi. Thyroid eye disease and ocular myasthenia gravis. Current opinion in neurology. 2024-11-28. PMID:39607029. |
an overview of two ocular diseases, which significantly impact quality of life: thyroid eye disease (ted) and ocular myasthenia gravis (omg). |
2024-11-28 |
2024-11-30 |
Not clear |
| Chenjun Guo, Ping Wang, Shaobo Zhang, Qilin Cheng, Qiong Zhang, Nan Ma, Yangjun L. Tocilizumab for the management of corticosteroid-resistant GO combined with OMG: a case series. BMC ophthalmology. vol 24. issue 1. 2024-11-27. PMID:39592974. |
to highlight the safety and efficacy of tocilizumab (tcz) in graves' ophthalmopathy (go) combined with ocular myasthenia gravis (omg) patients refractory to steroids and cholinesterase inhibitor (cei). |
2024-11-27 |
2024-11-29 |
Not clear |
| Youran Cai, Zhongyuan Cheng, Yuanting Yang, Baojun Xu, Qiwen Feng, Xu Liu, Jian Chen, Qing Zho. Differentiation and characterization of non-thymomatous ocular myasthenia gravis children with CT. Acta neurologica Belgica. 2024-10-30. PMID:39476226. |
differentiation and characterization of non-thymomatous ocular myasthenia gravis children with ct. to compare thymic features using unenhanced computed tomography (ct) images between children with non-thymomatous ocular myasthenia gravis (omg) and healthy children and determine the image feature cut-off values to allow differentiation of the two populations. |
2024-10-30 |
2024-11-02 |
Not clear |
| Byung Joo Lee, Jimin Park, Hyosook Ahn, Hyun Taek Li. Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity. Japanese journal of ophthalmology. 2024-10-02. PMID:39356387. |
to comparatively analyze the clinical characteristics of patients with ocular myasthenia gravis (omg) referred to an ophthalmology clinic, according to anti-acetylcholine receptor antibody (achr ab)-seropositivity. |
2024-10-02 |
2024-10-04 |
Not clear |
| Taimoor A Khan, Muhammad Zeshan Sadiq, Ali A Khan, Muhammad A Zahid, Sheharyar Zamee. Sero-Positive Isolated Ocular Myasthenia Gravis. Cureus. vol 16. issue 8. 2024-09-16. PMID:39280472. |
ocular myasthenia gravis (omg) is a neuromuscular disease characterized by the production of autoantibodies against post-synaptic proteins at the neuromuscular junction (nmj). |
2024-09-16 |
2024-09-19 |
Not clear |
| Kasper Holst Axelsen, Rebecca Kjær Andersen, Linda Kahr Andersen, John Vissing, Nanna Wittin. Ocular versus generalized myasthenia gravis: a continuum associated with acetylcholine receptor antibody titers. Neuromuscular disorders : NMD. vol 43. 2024-08-27. PMID:39190980. |
the aim of this study was to evaluate clinical and serological differences between the ocular myasthenia gravis (omg) and generalized mg (gmg). |
2024-08-27 |
2024-08-30 |
Not clear |
| Deepak Menon, Mohammed Alharbi, Hans D Katzberg, Vera Bril, Meg G Mendoza, Carolina Barnett-Tapi. Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis: A Retrospective Cohort Study. Neurology. vol 103. issue 4. 2024-07-30. PMID:39079067. |
early use of immunosuppression has been suggested to prevent generalization of ocular myasthenia gravis (omg), but high-quality evidence is limited in this regard. |
2024-07-30 |
2024-08-02 |
Not clear |
| Giuseppe Cosentino, Paolo Prunetti, Giulia Tammam, Chiara Zaffina, Matteo Gastaldi, Cristina Tassorelli, Enrico Alfonsi, Massimiliano Todisc. Diagnostic accuracy of voluntary and stimulated neuromuscular jitter studies in ocular myasthenia gravis. Muscle & nerve. 2024-07-13. PMID:39001646. |
the study aimed to compare these two techniques in the same population of patients with suspected ocular myasthenia gravis (omg). |
2024-07-13 |
2024-07-15 |
Not clear |
| Sui H Wong, Matthew James Bancroft, Vijay K Tailor, Mohamed Abbas, Akila Sekar, Claire Noble, Maria Theodorou, Diego Kask. Ocular myasthenia gravis saccades as a measure of extraocular muscle function. Frontiers in ophthalmology. vol 2. 2024-07-10. PMID:38983530. |
it is important to understand the pathophysiology of ocular myasthenia gravis (omg) to improve treatment. |
2024-07-10 |
2024-07-12 |
Not clear |
| Sui Hsien Won. Advocating Patient-Centred Research in Ocular Myasthenia Gravis (OMG): A Call for an OMG Research Consortium. Frontiers in ophthalmology. vol 2. 2024-07-10. PMID:38983533. |
advocating patient-centred research in ocular myasthenia gravis (omg): a call for an omg research consortium. |
2024-07-10 |
2024-07-12 |
Not clear |
| Jianqiang Li, Chujie Zhu, Mingming Zhao, Xi Xu, Linna Zhao, Wenxiu Cheng, Suqin Liu, Jingchen Zou, Ji-Jiang Yang, Jian Yi. OMGMed: Advanced System for Ocular Myasthenia Gravis Diagnosis via Eye Image Segmentation. Bioengineering (Basel, Switzerland). vol 11. issue 6. 2024-06-27. PMID:38927831. |
this paper presents an eye image segmentation-based computer-aided system for automatic diagnosis of ocular myasthenia gravis (omg), called omgmed. |
2024-06-27 |
2024-06-29 |
Not clear |
| Jaron C Sanchez, Markeeta T Belmar, Jason Sanchez, Joseph L Mercen, Jose Priet. A Male Patient Presents With Isolated Abducens Nerve Palsy: An Atypical Presentation of Ocular Myasthenia Gravis. Cureus. vol 16. issue 4. 2024-05-06. PMID:38707069. |
when myasthenia gravis is isolated to only ocular symptoms, it is referred to as ocular myasthenia gravis (omg). |
2024-05-06 |
2024-05-08 |
Not clear |
| Thanathon Anutraungkool, Tanyatuth Padungkiatsagul, Panitha Jindahra, Kavin Vanikiet. Prevalences of Other Non-Thyroid Autoimmune Diseases and Factor Associated with Their Presence in Ocular Myasthenia Gravis. Clinical ophthalmology (Auckland, N.Z.). vol 18. 2024-05-01. PMID:38686013. |
to report the prevalences of other non-thyroid autoimmune diseases and identify factors associated with their presence in ocular myasthenia gravis (omg) subjects. |
2024-05-01 |
2024-05-03 |
human |
| Yulia Valko, Magdalena A Wirth, Fabienne C Fierz, Marianne K Schesny, Sally Rosengren, Tanja Schmückle-Meier, Christopher J Bockisch, Dominik Straumann, Bettina Schreiner, Konrad P Webe. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia. Neurology. vol 102. issue 10. 2024-04-26. PMID:38669629. |
we developed repetitive ocular vestibular-evoked myogenic potentials (rovemp) as an electrophysiologic test that allows us to elicit the characteristic decrement of extraocular muscles in patients with ocular myasthenia gravis (omg). |
2024-04-26 |
2024-04-29 |
Not clear |
| Jan L De Bleecker, Gauthier Remiche, Alicia Alonso-Jiménez, Vinciane Van Parys, Véronique Bissay, Stéphanie Delstanche, Kristl G Claey. Recommendations for the management of myasthenia gravis in Belgium. Acta neurologica Belgica. 2024-04-22. PMID:38649556. |
it includes recommendations for treatment of adult patients with generalized myasthenia gravis (gmg) or ocular myasthenia gravis (omg). |
2024-04-22 |
2024-04-26 |
Not clear |
| Takuma Goto, Akiko Kimura, Akiko Masuda, Yoshihito Mochizuki, Fumi Gom. Clinical features of double seronegative ocular myasthenia gravis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2024-02-28. PMID:38416235. |
to clarify the clinical features of patients with double seronegative (ds) ocular myasthenia gravis (omg). |
2024-02-28 |
2024-03-01 |
Not clear |
| Miriam Kessi, Yulin Tang, Baiyu Chen, Guoli Wang, Ciliu Zhang, Fang He, Jing Peng, Fei Yin, Lifen Yan. Pediatric Ocular Myasthenia Gravis: Single-Center Experience. Pediatric neurology. vol 153. 2024-02-21. PMID:38382246. |
currently, there is no universally accepted standard treatment for ocular myasthenia gravis (omg) in children. |
2024-02-21 |
2024-02-24 |
Not clear |